Chemotherapy for Triple-Negative Breast Cancer: Is More Better?

被引：25
|
作者：
Mayer, Erica L. [1 ]
Burstein, Harold J.
机构：
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 28期
关键词：
PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT CISPLATIN; DOSE-DENSE; FOLLOW-UP; TRIAL; CYCLOPHOSPHAMIDE; BEVACIZUMAB; CARBOPLATIN; DOXORUBICIN; BENEFIT;
D O I：
10.1200/JCO.2016.68.4068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3369 / +
页数：4
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy in early stage Triple-Negative Breast Cancer Patients
    Pfeiler, G.
    Koenigsbergt, R.
    Natter, C.
    Jahn-Kuch, D.
    Hudec, M.
    Zeilinger, R.
    Dittrich, C.
    Singer, C.
    ONKOLOGIE, 2010, 33 : 26 - 26
  • [42] The role of circular RNAs in triple-negative breast cancer and chemotherapy resistance
    Wang, Xiyin
    Emch, Michael
    Hawse, John
    CANCER RESEARCH, 2023, 83 (05)
  • [43] Chemotherapy-related outcomes in triple-negative breast cancer.
    Wellmann, Rebecca M.
    Ghafouri, Sanaz N.
    McAndrew, Nicholas Patrick
    Hurvitz, Sara A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Gefitinib enhances response to chemotherapy in triple-negative Breast Cancer (BrCa)
    Corkery, B.
    O'Donovan, N.
    Clynes, M.
    Crown, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 185 - 185
  • [45] Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
    Guo, Qiusheng
    Lan, Tian
    Lu, Yunyan
    Hu, Zujian
    Xu, Haibin
    Wang, Xiaojia
    Shao, Xiying
    Fu, Xueyan
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (03): : 502 - 509
  • [46] Triple-Negative Breast Cancer Who Should Receive Neoadjuvant Chemotherapy?
    Chaudhary, Lubna N.
    Wilkinson, K. Hope
    Kong, Amanda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 27 (01) : 141 - +
  • [47] Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer
    Marti, Juan Luis Gomez
    Beckwitt, Colin H.
    Clark, Amanda M.
    Wells, Alan
    BRITISH JOURNAL OF CANCER, 2021, 125 (09) : 1285 - 1298
  • [48] The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
    Abraham, Jean E.
    Pinilla, Karen
    Dayimu, Alimu
    Grybowicz, Louise
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Vallier, Anne-Laure
    Hardy, Richard M.
    Chan, Steve
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, Mukesh B.
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola C.
    Mcadam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    Mcmurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena M.
    NATURE, 2024, 629 (8014) : 1142 - 1148
  • [49] Platinum-based chemotherapy for early triple-negative breast cancer
    Mason, Sofia R. E.
    Willsons, Melina L.
    Egger, Sam J.
    Beith, Jane
    Dear, Rachel F.
    Goodwin, Annabel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (09):
  • [50] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
12345